Detalhe da pesquisa
1.
Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses.
J Infect Dis;
211(4): 508-17, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25170104
2.
Immune correlates of herpes zoster in HIV-infected children and youth.
J Virol;
86(5): 2878-81, 2012 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22171274
3.
Humoral, mucosal, and cell-mediated immunity against vaccine and nonvaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected children.
J Infect Dis;
206(8): 1309-18, 2012 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22859825
4.
Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine.
Vaccine;
35(13): 1712-1720, 2017 03 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28238631
5.
Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
Pediatr Infect Dis J;
25(10): 920-9, 2006 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17006288
6.
Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection.
Pediatr Infect Dis J;
21(2): 119-25, 2002 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-11840078
7.
Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy.
Vaccine;
31(42): 4782-90, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23954381
8.
Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure.
AIDS Res Hum Retroviruses;
28(8): 780-8, 2012 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22081867
9.
T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines.
AIDS Res Hum Retroviruses;
26(1): 51-9, 2010 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20059397
10.
Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.
J Acquir Immune Defic Syndr;
55(2): 197-204, 2010 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20574412
11.
Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children.
J Acquir Immune Defic Syndr;
55(2): 189-96, 2010 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20581690
12.
Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays.
J Immunol Methods;
363(1): 42-50, 2010 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20888337
13.
Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization.
Clin Vaccine Immunol;
16(8): 1176-86, 2009 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19515870
14.
Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children.
Vaccine;
26(33): 4210-7, 2008 Aug 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18597900
15.
Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.
Pediatrics;
120(5): e1190-202, 2007 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17938165
16.
Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
J Infect Dis;
194(2): 247-55, 2006 Jul 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16779732